Utility of Preclinical Dosimetry for First-in-Human Studies with PET Drugs Labeled with Common Radionuclides: A Systematic Review of Radiation Dose Estimates. [PDF]
Koo H, Plyku D, Marzella L.
europepmc +1 more source
Repurposing radiopharmaceutical carriers for targeted drug delivery and theranostics: A translational framework. [PDF]
Shahiwala AF.
europepmc +1 more source
Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives. [PDF]
Bakr H +3 more
europepmc +1 more source
A Nondiagnostic 99mTc-PYP Scan with Absent Skeletal Uptake. [PDF]
Tokue H, Tokue A, Tsushima Y.
europepmc +1 more source
Correction: Eroglu et al. Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical. <i>Molecules</i> 2026, <i>31</i>, 654. [PDF]
Eroglu H, Ayan AK, Yenilmez A.
europepmc +1 more source
Targeted Alpha Therapy as a Multiscale Design Problem: From Radioactive Decay to Therapeutic Outcome. [PDF]
Lazić I +4 more
europepmc +1 more source
Optimization, automation and validation of NOP receptor PET radiopharmaceutical, [<sup>11</sup>C]NOP-1A for human use. [PDF]
Yokell DL +7 more
europepmc +1 more source
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts. [PDF]
Deandreis D +7 more
europepmc +1 more source
Dosimetry in <sup>177</sup>Lu-PRRT for Neuroendocrine Tumors: Current Concepts, Clinical Relevance and Future Perspectives. [PDF]
Poniatowska-Roszkowska ME +3 more
europepmc +1 more source

